Fagron, a leading provides pharmaceutical compounding services to hospitals, pharmacies, clinics, and patients worldwide, acquires Cedrosa, a supplier of raw materials to compounding pharmacies and the pharmaceutical industry, for $18.5m. The acquisition perfectly fits Fagron's buy-and-build strategy as it opens up the interesting Mexican market for personalized medicine. With its favorable demographics, a rapidly growing middle class and a focus on prevention and lifestyle, the Mexican market represents substantial growth potential for Fagron. "The Mexican market for personalized medicine presents a very promising opportunity for Fagron to expand our existing footprint in Latin America.", Rafael Padilla, Fagron CEO.